Industrials / Medical DistributionUpdated 2026-05-10 22:07 UTC

NSE/QMSMEDI stock hub

NSE/QMSMEDI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/QMSMEDIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/QMSMEDI

In the news

Latest news · NSE/QMSMEDI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 19.8P50 29.8P75 44.4

Trailing P/E13.7

P25 15.6P50 27.3P75 49.4

ROEn/a

P25 5.3P50 12.7P75 19.1

ROIC8.9

P25 4.5P50 9.9P75 16.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/QMSMEDI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

INR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	89
Employees Change	22%
Employees Change Percent	32.84
Enterprise value	INR 2.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Distribution
Isin	INE0FMW01018
Last refreshed	2026-05-10
Market cap	INR 1.6B
Price	INR 89
Price currency	INR
Rev Per Employee	19,442,126.87x
Sector	Industrials
Sic	5047
Symbol	nse/QMSMEDI
Website	https://qmsmas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.42%
EV Earnings	20.24x
EV/EBIT	10.69x
EV/EBITDA	9.33x
EV/Sales	1.38x
P/B ratio	1.29x
P/E ratio	13.74x
P/S ratio	0.92x
PE Ratio3 Y	21.93x
PE Ratio5 Y	22.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.89%
EBITDA Margin	14.78%
Gross margin	46.66%
Gross Profit	INR 807.4M
Gross Profit Growth	28.46%
Gross Profit Growth Q	-10.84%
Gross Profit Growth3 Y	39.22%
Gross Profit Growth5 Y	54.92%
Net Income	INR 117.9M
Net Income Growth	14.57%
Net Income Growth Q	-17.77%
Net Income Growth3 Y	7.04%
Net Income Growth5 Y	31.17%
Pretax Margin	10.57%
Profit Margin	6.81%
Profit Per Employee	INR 1.3M
Roa5y	11.45
Roe5y	30.9
ROIC	8.9
Roic5y	19.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.49%
Cagr3y	-12.99%
EPS Growth	12.45
EPS Growth Q	-23.93
EPS Growth3 Y	1.83
EPS Growth5 Y	26.28
Revenue Growth	20.4x
Revenue Growth Q	-15.06x
Revenue Growth3 Y	15.11x
Revenue Growth5 Y	27.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 33.1M
Debt	INR 649.4M
Debt EBITDA	INR 2.54
Debt Equity	INR 0.53
Equity	INR 1.2B
Interest Coverage	3.84
Net Cash	INR -616.3M
Net Cash By Market Cap	INR -38.79
Net Debt EBITDA	INR 2.41
Net Debt Equity	INR 0.5
Tangible Book Value	INR 726.2M
Tangible Book Value Per Share	INR 39.81
WACC	8.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.88%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	3
Dividend Yield	0.56%
Ex Div Date	2025-09-22
Last Dividend	INR 0.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.49%
200-day SMA	89.02
3Y total return	-34.13%
50-day SMA	83.98
50-day SMA vs 200-day SMA	50under200
All Time High	235.8
All Time High Change	-62.26%
All Time High Date	2022-12-05
All Time Low	68.95
All Time Low Change	29.08%
All Time Low Date	2026-03-17
ATR	3.94
Beta	0.8
Beta1y	0.43
Beta2y	0.07
Ch YTD	-0.67
High	89
High52	110.5
High52 Date	2025-09-19
High52ch	-19.46%
Low	89
Low52	68.95
Low52 Date	2026-03-17
Low52ch	29.08%
Ma50ch	5.98%
Price vs 200-day SMA	-0.02%
RSI	56.67
RSI Monthly	43.97
RSI Weekly	51.16
Sharpe ratio	0.24x
Sortino ratio	0.53
Total Return	-1.31%
Tr YTD	-0.67
Tr1m	8.54%
Tr1w	-4.2%
Tr3m	1.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 223.1M
Operating Income Growth	13.42
Operating Income Growth Q	-5.92
Operating Income Growth3 Y	14.46
Operating Income Growth5 Y	37.3
Operating margin	12.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,700,160%
Shares Insiders	73.67%
Shares Out	17,850,000
Shares Qo Q	6.01%
Shares Yo Y	1.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	7,650x
Bv Per Share	57.72
Ch1m	8.54
Ch1w	-4.2
Ch1y	-1.11
Ch3m	1.89
Ch3y	-35.67
Ch6m	-8.25
Change	0%
Change From Open	0
Close	89
Days Gap	0
Depreciation Amortization	32,724,090
Dollar Volume	356,000
Earnings Date	2026-05-21
EBIT	INR 223.1M
EBITDA	INR 255.8M
EPS	INR 6.48
F Score	2
Fiscal Year End	March
Founded	1,994
Graham Number	91.71298
Graham Upside	3.05
Income Tax	INR 47.9M
Is Primary Listing	1
Last Earnings Date	2026-02-14
Last Report Date	2025-12-31
Lynch Fair Value	INR 162
Lynch Upside	81.95
Ma150	91.46
Ma150ch	-2.69%
Ma20	85.38
Ma20ch	4.25%
Next Earnings Date	2026-05-21
Open	89
Payment Date	2025-10-29
Price Date	2026-05-08
Price EBITDA	INR 6.21
Ptbv Ratio	2.19
Relative Volume	0.5x
Revenue	1,730,349,291x
Tax By Revenue	2.77x
Tax Rate	26.17%
Tr6m	-8.25%
Volume	4,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/QMSMEDI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-1.3%

Next ex-dividend date: 2025-09-22

Performance

NSE/QMSMEDI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/QMSMEDI?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+73.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.9%

Negative means the company is buying back shares.

Technical

NSE/QMSMEDI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.7

Neutral momentum band

Price vs 200-day MA

-0.0%

50/200-day relationship not available

Beta (5Y)

0.80

Less volatile than the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/QMSMEDI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/QMSMEDI stock rating?

nse/QMSMEDI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/QMSMEDI analysis?

The full report lives at /stocks/nse/QMSMEDI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/QMSMEDI?

The latest report frames nse/QMSMEDI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/QMSMEDI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.